🏛️ Verified NIH Record • Updated 2026-08-11
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study (NCT05489588)
Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: W.L.Gore & Associates
🩺 Plain-English Summary (8th-Grade Level)
This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic iliofemoral venous obstruction.
Who can join: Review the eligibility criteria below.
Location: Stanford University School of Medicine — Stanford, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (24 Sites)
- Stanford University School of Medicine — Stanford, California
- Vascular Care Group — Darien, Connecticut
- Yale University — New Haven, Connecticut
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- Manatee Memorial Hospital — Bradenton, Florida
- Northwestern University — Chicago, Illinois
- Massachusetts General Hospital — Boston, Massachusetts
- Vascular Care Group — Wellesley, Massachusetts
- University of Michigan Hospital — Ann Arbor, Michigan
- Englewood Hospital & Med Center — Englewood, New Jersey
- Mount Sinai Medical Center — New York, New York
- Stony Brook — Stony Brook, New York
- University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
- Atrium Health-Sanger Heart and Vascular Institute — Charlotte, North Carolina
- NC Heart and Vascular Research — Raleigh, North Carolina
- Bethesda North — Cincinnati, Ohio
- University Hospitals Cleveland — Cleveland, Ohio
- Cleveland Clinic Foundation — Cleveland, Ohio
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- The Miriam Hospital — Providence, Rhode Island
- UT Southwestern — Dallas, Texas
- Sentara General Hospital — Norfolk, Virginia
- Overlake Hospital — Bellevue, Washington
- Medical College of Wisconsin - Froedtert Hospital — Milwaukee, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Thromboses
- The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study — Stanford, California
Explore by condition: All Venous Thromboses clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.